Pharmacological inhibition of CXCR2 using SB225002 prevented and even reversed hypertension‐induced AF susceptibility and atrial remodelling in SHRs, likely though the inhibition of macrophage infiltration and oxidative stress. This evidence concerns the gene CXCR2 and hypertensive disorder.